Clinical Trial Update: Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD [NA]

View source ↗

Summary

Clinical trial update on the combination therapy of Lucentis plus reduced-fluence photodynamic therapy with Visudyne for exudative age-related macular degenerat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: Barnes Retina Institute | Conditions: Age-Related Macular Degeneration | NA | Status: UNKNOWN